Chemours Company (The) (NYSE:CC) Insider Trading Update


Chemours Company (The) (NYSE:CC) has a 1 Year Target Estimate of $21.43. The stock traded with the volume of 2.67 Million in the last trading session. Chemours Company (The) opened at $22.9 and closed by showing an increase of 3.82%. The Bid price in the last session was $22.48 x 500 and the Ask price was $23.69 x 300. (The ask price is what sellers are willing to take for it. If you are selling a stock, you are going to get the bid price, if you are buying a stock you are going to get the ask price. The difference (or spread) goes to the broker/specialist that handles the transaction).

Chemours Company (The) has the Market Capitalization of 4.29 Billion. The Stock has its 52-week High of $23.9 and 52-Week Low of $3.06 and it touched its 52-week high on Nov 23, 2016 and 52-Week Low on Jan 27, 2016.

Chemours Company (The) reported its last Earnings on Nov 07 BMO where the company reported Actual EPS of $0.61/Share whereas, the Analyst Estimated EPS was $0.34/share. The difference between Actual EPS and Estimated EPS was $0.27/share. This represented an Earnings Surprise of 79.4%.

7 number of analysts also provided their insight on Chemours Company (The), where the Average Price Target for the stock is $21.43. They also projected Low Price Target as $13 while High Price Target is set at $25.

A number of analysts rated the stock as well: 0 analysts believe that the stock is a STRONG BUY while 0 reported it as Buy.0 analysts assigned a HOLD rating, 0 said it’s UNDERPERFORM and 0 say that this stock is a SELL.

Chemours Company (The) annual Divided is 0.12 while it’s Dividend Yield is 0.51%. The stock has its Price to Earnings (P/E) ratio of 28.88 and Forward Price to Earnings ratio of 13.06. The company has its Price to Sales (P/S) ratio of 0.79 where Price to Book (P/B) ratio of 11.36, Price to Cash Per share (P/C) of 4.49 and Price to Free Cash Flow (P/FCF) has a value of 17.68.

The company has its Return on Assets (ROA) of 2.4 Percent. Return on Equity (ROE) stands at 70.6% and Return on Investment (ROI) displays a value of -0.8%.

The stock is currently trading at Distance from 20-Day simple moving Average of 14.71% whereas, Distance from 50-Day Simple moving average is 34.02 Percent and Distance from 200-Day Simple Moving Average of 113.06 percent.

A look at performance overview of Chemours Company (The) depicts that Performance (Week) is 1.64 percent while Performance Month is 35.09%. Quarterly performance shows a value of 76.78% and Half Year Performance value stands at 169.5%. Yearly performance of the stock has the value of 282.5 percent. Chemours Company (The) has its YTD performance of 346.01 Percent. (YTD performance is the most important factor to consider; if YTD is negative, the stock is declining; if the YTD Performance value is Positive the stock is surging).

Insider Trades:

Many Insiders have done trades inside the company. The latest trade was made on 10 Nov 2016 where Chief Financial Officer Newman (Mark) did a transaction type “Sell” in which 10544 shares were traded at a price of $20.71. Another insider trade includes Officer Albright (Elizabeth) who also initiated a transaction in which 8445 shares were traded on 26 Oct 2016 as “Sell”. On 29 Jun 2016 Officer Trojanowski (Amy) traded 43 shares as “Sell” at $8.24. Director Brown (Richard H) Sell 10528 shares on 29 Jun 2016 at the price of $8.24.

Upgrades/Downgrades Report:

The latest Upgrades/Downgrades was done by Research firm Goldman on 14-Mar-16 who Upgrade the stock from Neutral to Buy. Other firms have also Upgraded/Downgraded the stock. On 16-Feb-16, Jefferies took an action “Downgrade” from Buy to Hold. On 18-Sep-15, the stock was Initiated to Hold by Argus.